ClinicalTrials.Veeva

Menu

Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation

U

University Medical Center Groningen (UMCG)

Status

Enrolling

Conditions

Lung Cancer

Treatments

Radiation: Radiotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT02421718
SFP LUNG

Details and patient eligibility

About

Motive:

In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from lung cancer patients.

Goal:

To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.

A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

Enrollment

10,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with NSCLC or SCLC-LD or thymoma or lung metastases (treated with stereotactic radiotherapy)
  • Patients receiving radiotherapy dose > 40 Gy

Exclusion criteria

  • Failure to comply with any of the inclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Robin Wijsman, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems